CJC1295 without DAC
Modified GRF (1-29), CJC-1295 no DAC
Modified Growth Releasing Factor aminos 1-29, usually referred to as Modified GRF (1-29) or “ModGRF(1-29),” also known as CJC-1295 without DAC, is a synthetic analog of the endogenous peptide signaling hormone Growth Hormone Releasing Hormone (GHRH). Endogenously produced GHRH has 44 amino acids in its chain structure. A truncated synthetic form of GHRH called Sermorelin or GRF 1-29 has 29 amino acids; Modified GRF (1-29) is further changed in that it has four substituted aminos in its chain that serve the purposes of preventing degradation and oxidation in manufacture and transport as well as in vivo, while also increasing binding affinity to the GHRH receptors.
Modified GRF (1-29) is not CJC-1293 nor should it be referred to as such. Modified GRF (1-29) is identical to the portion of CJC-1295 DAC that is not bound to MPA, minus the lysine. The presence of lysine in a literal “CJC without DAC” in the absence of MPA would have the opposite effect of DAC: it would drastically reduce the active life of the peptide to that of Sermorelin. Modified GRF (1-29) is the same as CJC-1295 with out DAC.
Molecular weight: 3367.2
Peptide purity: > 98.0%
Appearance: White powder
Related substance: Total Impurities(%) ≤ 2.0%
Acetate content: ≤ 15.0%
Bacterial Endotoxins: ≤5 IU/mg
Benefits of CJC-1295 without DAC
According to scientific study on animal test subjects, CJC-1295 No DAC is linked to a host of theoretical benefits. Some of these benefits include:
The boosting of protein synthesis – Scientific study on animal test subjects have shown that the peptide can aid in the inhibition of cellular degradation. This enables the test subject to carry a greater amount of cellular receptors and therefore more producers of proteins.
The reduction of body fat – CJC-1295’s mechanics have demonstrated an ability to promote the process where lipids are broken down. This accelerated degradation of lipids enables body fat to decrease on a much more efficient basis.
Increased muscle tissue growth – The increase in protein synthesis is linked to an increased proliferation of muscle cells. This in turn translates to an increase in the mass and size of muscles found amongst animal test subjects.
Quicker recovery from injury – Because CJC-1295 No DAC boosts the production of protein, it is theorized that such an elevated process can allow for a more efficient healing process to occur within animal test subjects.
Stronger immune system – The increase in protein that CJC-1295 No DAC can bring also has been shown to boost animal test subjects’ capability to fend off sickness on a more efficient basis.
Increased bone density –Scientific study on animal test subjects have determined that the peptide’s presence over a period of time can cause an uptick in the generation of a bone’s mineral manner per square centimeter. This in turn leads to stronger bones that are less susceptible to fractures and other bone-related injuries.